Literature DB >> 24086858

Herpes Simplex Encephalitis (HSE) and its outcome in the Patients who were Admitted to a Tertiary Care Hospital in Mashhad, Iran, over a 10-year Period.

F Sheybani1, H R Arabikhan, H R Naderi.   

Abstract

INTRODUCTION: The effective cure rate of acyclovir emphasizes the importance of an early diagnosis and treatment in reducing the considerable mortality and the morbidity in patients with Herpes Simplex Encephalitis (HSE).
METHODS: The demographic as well as clinical features, the lab data and the neuroimaging findings of the patients with HSE, which were confirmed by Cerebrospinal Fluid (CSF) PCR and/or brain MRI, were reviewed and analyzed statistically over a 10-year period.
RESULTS: Over a 10-year period, the characteristics of 45 patients with HSE were reviewed. 34 (76%) out of the 45 patients showed positive CSF HSV-1 PCR results. 8 (18%) had a normal CSF analysis and a CSF/blood glucose ratio of less than 0.5 was observed in 13 (29%) patients, while 14% had PMN-dominant pleocytosis. 68% of the patients for whom brain MRI was performed, had temporal lobe involvement. While 37 (83%) patients recovered completely, 6 (13%) survived with sequelae, and 2 (4%) died.
CONCLUSION: Because of the increasing number of atypical forms of HSE and the great impact of an early diagnosis and treatment on a favourable outcome, the acyclovir therapy should be administrated for any type of febrile encephalopathy of unknown aetiology, until HSE can be excluded.

Entities:  

Keywords:  Acyclovir; Febrile encephalopathy; Herpes Simplex Encephalitis (HSE); PCR

Year:  2013        PMID: 24086858      PMCID: PMC3782915          DOI: 10.7860/JCDR/2013/5661.3221

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  16 in total

1.  Hypoglycorrhachia in herpes simplex encephalitis.

Authors:  Rebecca Davis; Katie Jeffery; Bridget L Atkins
Journal:  Clin Infect Dis       Date:  2004-05-15       Impact factor: 9.079

2.  Herpes simplex virus encephalitis despite normal cell count in the cerebrospinal fluid.

Authors:  Nurith J Jakob; Thorsten Lenhard; Paul Schnitzler; Stefan Rohde; Peter A Ringleb; Thorsten Steiner; Brigitte Wildemann
Journal:  Crit Care Med       Date:  2012-04       Impact factor: 7.598

3.  The diagnostic usefulness of cerebrospinal fluid lactic acid levels in central nervous system infections.

Authors:  Burke A Cunha
Journal:  Clin Infect Dis       Date:  2004-10-15       Impact factor: 9.079

4.  [Herpetic encephalitis: case series of 15 patients confirmed by polymerase chain reaction].

Authors:  Alberto Fica; Carlos Pérez; Paula Reyes; Sandra Gallardo; Ximena Calvo; Ana M Salinas
Journal:  Rev Chilena Infectol       Date:  2005-03-04       Impact factor: 0.520

5.  Outcome of herpes simplex encephalitis in children.

Authors:  Wen Bin Hsieh; Nan Chang Chiu; Kun Chieh Hu; Che Sheng Ho; Fu Yuan Huang
Journal:  J Microbiol Immunol Infect       Date:  2007-02       Impact factor: 4.399

6.  Diseases that mimic herpes simplex encephalitis. Diagnosis, presentation, and outcome. NIAD Collaborative Antiviral Study Group.

Authors:  R J Whitley; C G Cobbs; C A Alford; S J Soong; M S Hirsch; J D Connor; L Corey; D F Hanley; M Levin; D A Powell
Journal:  JAMA       Date:  1989-07-14       Impact factor: 56.272

Review 7.  Herpes simplex encephalitis: a review.

Authors:  R E Levitz
Journal:  Heart Lung       Date:  1998 May-Jun       Impact factor: 2.210

8.  Factors associated with delay to acyclovir administration in 184 patients with herpes simplex virus encephalitis.

Authors:  J Poissy; M Wolff; A Dewilde; F Rozenberg; F Raschilas; M Blas; H Georges; C Chaffaut; Y Yazdanpanah
Journal:  Clin Microbiol Infect       Date:  2009-04-21       Impact factor: 8.067

9.  Diagnosis of herpes simplex encephalitis by magnetic resonance imaging and polymerase chain reaction assay of cerebrospinal fluid.

Authors:  R B Domingues; M C Fink; A M Tsanaclis; C C de Castro; G G Cerri; M S Mayo; F D Lakeman
Journal:  J Neurol Sci       Date:  1998-05-07       Impact factor: 3.181

10.  Herpes simplex virus type 2 as a cause of severe meningitis in immunocompromised adults.

Authors:  Hervé Momméja-Marin; Matthieu Lafaurie; Catherine Scieux; Lionel Galicier; Eric Oksenhendler; Jean-Michel Molina
Journal:  Clin Infect Dis       Date:  2003-11-06       Impact factor: 9.079

View more
  6 in total

1.  Results of a multinational study suggest the need for rapid diagnosis and early antiviral treatment at the onset of herpetic meningoencephalitis.

Authors:  Hakan Erdem; Yasemin Cag; Derya Ozturk-Engin; Sylviane Defres; Selcuk Kaya; Lykke Larsen; Mario Poljak; Bruno Barsic; Xavier Argemi; Signe Maj Sørensen; Anne Lisbeth Bohr; Pierre Tattevin; Jesper Damsgaard Gunst; Lenka Baštáková; Matjaž Jereb; Isik Somuncu Johansen; Oguz Karabay; Abdullah Umut Pekok; Oguz Resat Sipahi; Mahtab Chehri; Guillaume Beraud; Ghaydaa Shehata; Rosa Fontana Del Vecchio; Mauro Maresca; Hasan Karsen; Gonul Sengoz; Mustafa Sunbul; Gulden Yilmaz; Hava Yilmaz; Ahmad Sharif-Yakan; Souha Shararah Kanj; Emine Parlak; Filiz Pehlivanoglu; Fatime Korkmaz; Suheyla Komur; Sukran Kose; Mehmet Ulug; Sibel Bolukcu; Seher Ayten Coskuner; Nevin Ince; Yasemin Akkoyunlu; Gulistan Halac; Elif Sahin-Horasan; Hulya Tireli; Gamze Kilicoglu; Akram Al-Mahdawi; Salih Atakan Nemli; Asuman Inan; Seniha Senbayrak; Jean Paul Stahl; Haluk Vahaboglu
Journal:  Antimicrob Agents Chemother       Date:  2015-03-16       Impact factor: 5.191

2.  Burden of herpes simplex virus encephalitis in the United States.

Authors:  S Modi; Abhimanyu Mahajan; D Dharaiya; P Varelas; P Mitsias
Journal:  J Neurol       Date:  2017-05-17       Impact factor: 4.849

3.  Predictors of outcome in HSV encephalitis.

Authors:  Tarun D Singh; Jennifer E Fugate; Sara Hocker; Eelco F M Wijdicks; Allen J Aksamit; Alejandro A Rabinstein
Journal:  J Neurol       Date:  2015-11-14       Impact factor: 4.849

4.  A study on viral CNS inflammation beyond herpes encephalitis.

Authors:  Berit Jordan; Sabrina Kösling; Alexander Emmer; Antje Koch; Tobias Müller; Malte Kornhuber
Journal:  J Neurovirol       Date:  2016-05-12       Impact factor: 3.739

Review 5.  The prevalence of herpes simplex virus type 1 and 2 infection in Iran: A meta-analysis.

Authors:  Mina Malary; Ghasem Abedi; Zeinab Hamzehgardeshi; Mahdi Afshari; Mahmood Moosazadeh
Journal:  Int J Reprod Biomed (Yazd)       Date:  2016-10

6.  HSV-1 Encephalitis: High Index of Clinical Suspicion, Prompt Diagnosis, and Early Therapeutic Intervention Are the Triptych of Success-Report of Two Cases and Comprehensive Review of the Literature.

Authors:  Dimitrios Patoulias; Georgios Gavriiloglou; Konstantinos Kontotasios; Mairi Tzakri; Petros Keryttopoulos; Christos Koutras
Journal:  Case Rep Med       Date:  2017-08-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.